A detailed history of Parallax Volatility Advisers, L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 44,626 shares of ABBV stock, worth $7.57 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
44,626
Previous 33,194 34.44%
Holding current value
$7.57 Million
Previous $5.69 Million 54.79%
% of portfolio
0.02%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $1.87 Million - $2.28 Million
11,432 Added 34.44%
44,626 $8.81 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $3.72 Million - $4.34 Million
24,012 Added 261.51%
33,194 $5.69 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $1.47 Million - $1.67 Million
9,182 New
9,182 $1.67 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $3.83 Million - $4.43 Million
28,649 New
28,649 $4.27 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $2.63 Million - $3.03 Million
-18,169 Reduced 35.11%
33,583 $5.35 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $4.39 Million - $5.27 Million
-31,754 Reduced 38.03%
51,752 $8.37 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $11.2 Million - $12.9 Million
83,506 New
83,506 $11.2 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $39.9 Million - $44 Million
-390,432 Reduced 84.65%
70,788 $7.66 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $33.2 Million - $44.8 Million
411,885 Added 834.87%
461,220 $49.4 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $7.36 Million - $8.64 Million
-85,719 Reduced 63.47%
49,335 $4.32 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $71,535 - $95,725
-975 Reduced 0.72%
135,054 $13.3 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $7.84 Million - $11.9 Million
121,555 Added 839.82%
136,029 $10.4 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $1.04 Million - $1.3 Million
14,379 Added 15135.79%
14,474 $1.28 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $5.6 Million - $6.73 Million
-88,879 Reduced 99.89%
95 $7,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $4.59 Million - $5.87 Million
69,903 Added 366.54%
88,974 $6.47 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $18.1 Million - $21.4 Million
-235,202 Reduced 92.5%
19,071 $1.54 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $19.8 Million - $24.4 Million
253,703 Added 44509.3%
254,273 $23.4 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $893,849 - $1.06 Million
-9,956 Reduced 94.58%
570 $53,000
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $2.46 Million - $3.29 Million
-26,714 Reduced 71.73%
10,526 $996,000
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $3.34 Million - $3.66 Million
37,240
37,240 $3.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.